Sparsentan - Travere Therapeutics
At a glance
- Drug Originator Bristol-Myers Squibb
- Drug Licenced by CSL Vifor; Ligand Pharmaceuticals; Renalys Pharma; Travere Therapeutics
- Drug Class Anti-inflammatories; Antihypertensives; Isoxazoles; Nerve growth factors; Small molecules; Spiro compounds; Sulfonamides; Urologics; Vascular disorder therapies
- Mechanism of Action Angiotensin type 2 receptor antagonists; Endothelin A receptor antagonists
- USA Patent Applicants TRAVERE
- USA Patents 2
- NDAs 1
- International Patents 29
- Patent Applications 61
Disclaimer